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Abstract 
 
Objective 
 The purpose of this study is to evaluate the relationship between body mass and 
depression among Mississippi women with polycystic ovarian syndrome (PCOS).   
 
Methods  
 Ten women participated in this study.  Data was collected by online survey.  The 
survey was distributed to eligible participants on pcoschallenge.com, a support network 
for women with PCOS.  The survey included the Center for Epidemiologic Studies 
Depression (CES-D) questionnaire as well as five additional questions that asked the 
participants to report their weight, height, comorbidities, age, and race.  The CES-D score 
provided a measurement for depression while the participant’s weight and height allowed 
the researcher to calculate body mass index (BMI), the measurement used for body mass.  
The participants’ depression scores and BMI scores were analyzed using Pearson’s 
correlation coefficient. 
 
Results 
With all 10 participants the BMI scores and CES-D scores were negatively 
correlated (r = -0.173).  The maximum BMI score of 62.02 and the minimum CES-D 
score of 8 belonged to the same participant, participant 10.  Because participant 10 
possessed the maximum BMI and the minimum CES-D score, she could have affected 
standard deviation.  For experimental purposes the data was analyzed again without 
participant 10’s BMI score or CES-D score.  Without participant 10’s data, the BMI and 
CES-D scores for the remaining nine participants were positively correlated (r = 0.294).   
 
Conclusion  
With the inclusion of participant 10’s data, the finding that body mass and 
depression were negatively correlated (r = -0.173) does not reflect the findings of past 
research.  Without participant 10’s data the results were positively correlated (r = 0.294), 
which is congruent with the findings of past research (Barry et al., 2011).  The findings of 
this study are conflicting.  In the current study p > 0.05.  Therefore, the results are not 
clinically significant.  Limitations to this study include a small sample size as well as a 
lack of representation of individuals without access to the Internet.  Future research needs 
to be conducted with a larger sample to further examine the relationship between body 
mass and depression in women with PCOS.    
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Chapter 1 
Purpose of the Study 
About 5-10% of women worldwide suffer from PCOS, a chronic endocrine 
disorder that affects metabolism and fertility.  A diagnosis of PCOS includes 2 out of 3 
criteria: (1) hyperandrogenism, (2) amenorrhea or oligomennorrhea, and (3) polycystic 
ovaries (Shannon & Wang, 2012).  Because PCOS affects metabolism, it can cause 
distressing and unwanted symptoms such as weight-gain, abdominal obesity and 
hirsutism.  In addition to causing psychologically disturbing symptoms, PCOS increases 
a woman’s risk of developing depression (Coffey & Mason, 2003).  To date, no study has 
examined a sample of women with PCOS from Mississippi.  The aim of this study is to 
examine the relationship between body mass and depression among Mississippi women 
with PCOS. 
PCOS and Depression 
In 2000 it was estimated that about 70% of women with PCOS were obese (Lim, 
Norman, Davies & Moran, 2013).  Ching, Burke, and Stuckey (2007) noted that women 
with PCOS not only suffered from obesity, but also from obesity related comorbidities 
such as insulin resistance, dyslipidemia, glucose intolerance, and depression.  Women 
with PCOS did not have to be overweight or obese to experience these comorbidities.  
However, having a higher body mass increased the risk of comorbidities such as insulin 
resistance, dyslipdemia, glucose intolerance, and depression (Lim, et al., 2013).  Body 
mass is important to address in women with PCOS because it not only threatens their 
physical health, but also their psychological health.   
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In addition to experiencing weight gain and obesity related comorbidities, women 
with PCOS experienced manifestations of hyperandrogenism including hirsutism, hair 
loss, and acne (Shannon & Wang, 2012).  Women with PCOS were more often 
concerned with symptoms that affected appearance, such as weight-gain and hirsutism, 
than they were with symptoms such as menstrual irregularity or infertility.  Furthermore, 
decreased health related quality of life was related to symptoms such as acne, hirsutism, 
and diabetes mellitus in women with PCOS.  This finding suggests that PCOS is just as 
psychologically burdening as it is physically (Coffey & Mason, 2003).   
The psychological implications of PCOS are evident from the findings of past 
research.  Women with PCOS were more likely to suffer from depression, psychological 
morbidities, and an increased response to stress.  Also, women with PCOS reported that 
they suffered from low self-esteem, decreased social activity, and decreased romantic 
contentment (Coffey & Mason, 2003).   
Depression and Increased Body Mass 
Being overweight or obese was associated with increased depression, especially 
in women with PCOS (Barry, Kuczmierczyk, and Hardiman, 2011).  Even after receiving 
medical treatment for symptoms, psychological distress persisted in women with PCOS, 
causing decreased quality of life.  For example, women who were treated for hirsutism 
did not experience a decrease in depression (Coffey & Mason, 2003).  If these women 
were initially treated for depression instead of hirsutism exclusively, perhaps a decrease 
in depression would have resulted.  
People with a medical illness who suffered from depression had more severe 
symptoms of depression and their medical illness.  They were also less likely to adapt to 
   
3 
 
their medical illness (Cassano & Favo, 2002).  Treating the depression improved the 
outcome of any concurrent medical illness (Katon & Ciechhanowski, 2002).   
One type of depression, major depressive disorder (MDD) has been found to 
cause symptoms such as anhedonia, weight-gain or loss, insomnia or hyperinsomnia, 
fatigue or loss of energy, psychomotor retardation, and suicidal ideation.  Assessing the 
risk of suicide in patients with depression was vital to safety, because a depressed 
individual was at an increased risk to harm her self or others (Greenberg, Tesfazion & 
Robinson, 2012). 
Purpose 
Mississippi has one of the highest obesity rates in the country.  More than 30% of 
the population was classified as obese in 2010 (Majumdar, Morris, Gordon, Kermode, 
Forsythe, Herrington, & Iyer, 2010).  Women living in Mississippi with PCOS could 
potentially be at a higher risk for becoming overweight or obese.  Therefore, it is 
important to determine if there is a significant relationship between body mass and 
depression in Mississippi women with PCOS so that at-risk populations can be identified. 
The psychological profile of women with PCOS needs to be further explored so 
that risk factors related to decreased psychological health can be identified.  This will 
allow healthcare providers to develop a more comprehensive PCOS treatment plan that 
addresses both physical and psychological health.       
 Previous research has been inconsistent regarding the relationship between 
obesity and depression.  No study found to date has evaluated the relationship between 
body mass and depression in Mississippi women with PCOS.  This study will attempt to 
provide new knowledge that can be utilized by Mississippi healthcare providers when 
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assessing and treating women with PCOS.  Therefore, this study attempts to answer the 
question: What is the relationship between body mass and depression among Mississippi 
women with PCOS? 
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Chapter II 
Literature Review 
 Past researchers found that many women with PCOS experienced comorbid 
conditions related to obesity such as depression and cardiovascular disease (Zhao, Ford, 
Dhingra, Strine, & Mokdad, 2009).  Studies done in the United States showed that in 
2000-2002 about 74% of women with PCOS were obese (Yildiz, Knochenhauer, & 
Azziz, 2008).  PCOS, while clearly a physiological disease, also affected psychological 
health, resulting in a decreased quality of life and a higher risk for depression (Deeks, 
Gibson-Helm, & Teede, 2010, Upadhya & Trent, 2003, Himelein & Thatcher, 2006, Li, 
Yu Ng, & Stener-Victorin, 2011).  Being overweight or obese increased the risk of 
developing depression, especially among overweight and obese women with PCOS 
(Barry et al., 2011).  Increased body mass should be addressed in women with PCOS 
because it has been found to affect not only psychological health, but metabolic and 
reproductive health as well (Lim et al., 2013). 
Impact of Body Mass on PCOS Metabolic and Reproductive Features 
Lim, et al. (2013) investigated the effect obesity had on the psychological, 
metabolic, and reproductive features of PCOS by extracting data from thirty studies and 
comparing the findings. Only three of the thirty studies were conducted in the Americas 
so findings may not be entirely representative of women in the United States.  Findings 
about the effect of obesity on the psychological, metabolic, and reproductive features of 
PCOS have been inconsistent in the past, thus this study attempted to further explore the 
topic.  Lim et al.’s (2013) study provided a better understanding of how increased body 
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mass affected the physical features of PCOS, which may have contributed to its 
psychological features. 
Lim et al. (2013) defined being overweight as having a BMI score of >25 kg/m2 
and being obese as having a BMI score of >30 kg/m2.  Asians were considered 
overweight with a BMI score of >23 and obese with a BMI score of >25.  Adolescent 
participants were measured for BMI using age and gender specific Centers for Disease 
Control growth charts (85
th
-95
th
 percentile overweight and >95
th
 percentile obese).  BMI 
classifications for this study were well defined and accounted for variances in BMI 
classification criteria caused by race, gender, and age.   
Compared to normal weight women, overweight women with PCOS were found 
to have decreased sex hormone binding globulin and increased fasting insulin, fasting 
glucose, and triglycerides.  No difference was found in total testosterone, hirsutism, total 
cholesterol and LDL cholesterol between the two groups (Lim et al., 2013).   
Compared to normal weight women, obese women had decreased sex hormone 
binding globulin and high-density lipoprotein (HDL) cholesterol, and increased total 
testosterone, fasting insulin, total cholesterol, LDL cholesterol, and triglycerides.  
Increased fasting insulin, blood glucose, and increased cholesterol levels contributed to 
type II diabetes and coronary heart disease, both of which were associated with PCOS 
(Ehrmann, Barnes, Rosenfield, Cavaghan, & Imperial, 1999, Legro, 2003).  Type II 
diabetes and coronary artery disease negatively affected psychological health as well as 
contributed to the increased risk for stroke and coronary artery disease in women with 
PCOS (de Groot, Dekkers, Romijn, Dieben, & Helmerhorst, 2011, Zhao et al., 2009).  
While this study did explore the relationship of body mass and the metabolic, 
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reproductive, and psychological features of PCOS, it did not explore the relationship 
between the metabolic, reproductive, and psychological features of PCOS. 
Cinar, Kizilarslanoglu, Harmanci, Aksoy, Bozdag, Demir, and Yildiz (2011) 
conducted a study to explore the relationship between PCOS and depression as well as 
the metabolic aspect of PCOS and its effect on depression.  This study included 226 
participants with PCOS and 85 controls without PCOS who were matched for BMI.  
Participants did not take medications for 3 months prior to the test, which ensured more 
accurate results as some medications may affect depression (Barry, et al., 2011, Barnard, 
Ferriday, Guenther, Strauss, Balen, & Dye, 2007).  The Beck Depression Inventory, a 
commonly used tool to measure depression, was used.  Results concluded that 28.6% of 
women with PCOS scored as clinically depressed whereas 4.7% of women without 
PCOS scored the same (Cinar et al., 2011).  Normal weight and overweight women with 
PCOS scored lower on the depression scale than obese women with PCOS.   
Cinar et al. (2011) were able to identify a relationship between depression, 
postload glucose, insulin resistance and increased lipids.  Past researchers had presented 
conflicted findings about the correlation between depression and cardiometabolic features 
of PCOS.  Rasgon, Rao, Hwang, Altshuler, Elman, Zuckerbrow-Milller, & Korenman 
(2003) correlated only increased insulin resistance and increased body mass with 
depression.  Further research needs to be conducted in order to determine the exact 
relationship between metabolic features of PCOS and depression.  Cinar et al. (2011) 
concluded that depression and decreased quality of life in women with PCOS was related 
to increased body mass and cardiometabolic features of the disease.  Little research has 
been done to explore the relationship between body mass and cardiac risk in PCOS.  
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Body Mass, Obesity-related Comorbidities and PCOS 
 De Groot et al. (2011) conducted research to evaluate whether or not obesity 
increased the risk of stroke and coronary heart disease in women with PCOS.  Five 
articles published between 2000 and 2008 were evaluated.  Each of the articles compared 
women with PCOS to a control group of women without PCOS.  Obesity criteria for this 
study matched the criteria of the American Medical Association (2010) and WHO’s 
(2006) classification of obesity (BMI >30 kg/m2 and a waist circumference of >88 cm).  
Results indicated that women with PCOS were twice as likely to develop coronary heart 
disease or stroke.  After BMI scores were adjusted for demographic factors, there was an 
increased risk of 55% (De Groot et al., 2011).  While increased body mass may not 
necessarily be the cause of coronary heart disease or stroke in a woman with PCOS, it is 
important to address increased body mass because it increases a woman’s risk of 
depression and decreases her quality of life (Deeks et al., 2010, Himelein & Thatcher, 
2006, Li et al., 2011, Upadhya &Trent, 2003, Zhao et al., 2009). 
Body Mass and Depression 
Zhao et al. (2009) used a telephone survey to involve 177,047 U.S. citizens, 18 
years or older, in a study to measure anxiety and depression related to body mass.  
Participants were asked about their weight, depression level, possible chronic psychiatric 
diagnoses, obesity related comorbidities (diabetes, heart disease, etc.), demographics, 
lifestyle factors (smoking, drinking, leisure time, exercise, etc.), and overall general 
health.  Few previous studies had been conducted to evaluate how obesity related 
comorbidities, lifestyle choices, and psychosocial factors affected mental health in obese 
individuals.  Since weight was self-reported over the phone in this study, it is possible 
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that it was falsely self-reported.  In fact, Zhao et al. (2009) reported a 26.0% obesity rate, 
which is less than the national obesity rate of 32.2% reported by Ogden, Carroll, Curtin, 
McDowell, Tabak, and Flegal (2006).  Thus, the relationship between obesity and 
depression may be underreported in this study.   
In this study BMI scores were categorized as <18.5 kg/m2 (underweight), 18.5-
<25 kg/m2 (normal weight), 25-<30 kg/m2 (overweight), 30-<35 kg/m2 (class I obesity), 
34-<40 kg/m2 (class II obesity) and >40 kg/m2 (class III obesity), thus this study used 
standard categorization of BMI.  Demographics including gender were analyzed in this 
study.  Women who were underweight (<18.5 kg/m2) or overweight or obese (>25) were 
more likely to experience depression or have a diagnosis of chronic depression or anxiety 
(Zhao et al., 2009).    
Results correlating body mass and mental health were determined after 
adjustment for other demographic variables, obesity related comorbidities, lifestyle 
factors, and overall general health.  Even after adjustment results supported the 
established finding that increased body mass is a significant predictor of depression as 
well as anxiety (Zhao et al., 2009).    
Previous studies have shown that people with diabetes or coronary heart disease 
were more likely to suffer from depression (Chiung-Yu, Shu-Ching, Sousa, Chao-Ping, & 
Kuei-Ching, 2011).  Zhao et al. (2009) found that people with obesity comorbidities such 
as diabetes, myocardial infarction, angina pectoris, stroke or asthma were more likely to 
have anxiety and depression than those without obesity comorbidities.  Zhao et al.’s study 
was limited due to the fact that it only evaluated five obesity-related comorbidities while 
excluding others (hypertension, gallbladder disease, osteoarthritis, etc.).   
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PCOS could be considered an obesity-related comorbidity as up to 74% of women 
with PCOS are considered overweight or obese (Yildiz, Knochenhauer, & Azziz, 2008).  
Furthermore, PCOS has been linked to obesity-related comorbidities such as stroke, 
coronary heart disease and depression (de Groot et al., 2011).  
PCOS and Depression 
Barry, et al.’s (2011) systematic review and meta-analysis of 12 previous studies 
supported former research findings that suggested depression was more common in 
women with PCOS than women without PCOS.  About 2257 participants were included 
in this research (910 with PCOS and 1347 without).  Participants were recruited from a 
variety of places (med school, friends and family, internet) so the results may have been 
influenced by biases (Barry et al., 2011).   
Women with PCOS had statistically significant higher rates of depression than 
women without PCOS.  Barry et al. (2011) suggested that, in clinical terms, this was 
comparable to finding that women with PCOS experienced mild depression whereas 
women without PCOS experienced no depression.  While a difference was found in 
depression rates among women who had PCOS versus women who did not have PCOS, 
the difference had limited clinical significance.  However, 15% of women with PCOS 
scored in the moderate to severe depression range (Barry et al., 2011).  The psychological 
implications of PCOS need to be further addressed as this study showed that some 
woman with PCOS might be at higher risk than others.   
Barry et al. (2011) also suggested that women with PCOS in their twenties and 
thirties were more likely to be depressed than adolescents with PCOS.  More research on 
adolescents with PCOS needs to be conducted to further explore this finding.  Barry et al. 
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(2011) did explore how medication, age, and increased body mass could increase the risk 
of depression, but it did not explore how lifestyle factors, comorbid conditions, and 
demographics affected risk for depression in women with PCOS.  
Possible Link Between Decreased Depression and Medication Use in PCOS 
Barry et al. (2011) found that women with PCOS taking anti-androgen 
medications were less likely to be depressed than women not taking anti-androgen 
medications.  These results supported the findings of Barnard et al. (2007) but conflicted 
with the findings of Rasgon et al. (2003).  However, Barry et al. (2011) revealed that each 
study used different scales and defined medication use differently so these results should 
be carefully interpreted.  The use of medications to treat PCOS and its effect on 
depression should be further explored in the future, or participants of studies should at 
least identify whether or not they are using medication. 
PCOS, Increased Body Mass and Depression  
Women with PCOS with increased BMI scores were found to experience higher 
rates of depression (Barry et al., 2011).  Barry et al. (2011) found that studies that did not 
control for BMI had a greater difference of depression levels between the controlled 
matches for BMI scores of the PCOS group and the control group.  Barry et al. (2011) 
stated that this further signified the relationship between increased body mass and 
increased depression in women with PCOS. 
Notable in reviewing these studies that examined the relationship between BMI, 
cardiac risk associated with PCOS, and depression, is the fact that all were conducted 
outside the state of Mississippi.  To date, studies that sampled Mississippi women have 
not been found.  Therefore, this research study seeks to address the question, what is the 
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relationship between depression and body mass among Mississippi women with PCOS? 
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Chapter III 
Methodology 
Participants  
Participant Inclusion Criteria: 
  1. 21 years of age or older 
  2. Diagnosis of PCOS from a gynecologist or endocrinologist  
  3. Currently residing in Mississippi  
All women surveyed were members of the online PCOS support group, 
pcoschallenge.com, a networking website that provides an online community for women 
with PCOS.  Because only about 10% of women have PCOS, it was anticipated that 
participants would be difficult to encounter in person.  With over 21,000 members, 
pcoschallenge.com provided access to the desired sample.  About 106 women from 
Mississippi, who were members of pcoschallenge.com, were invited to participate in the 
study.  Prospective participants were informed of the inclusion criteria, which was self-
reported.  Only 10 women chose to participate.  Women with chronic diseases were 
included in the study due to a low response rate.  A control group of healthy individuals 
was not used for comparison because the relationship between BMI and depression in 
women with PCOS and women without PCOS has been previously compared and well 
documented by past research (Deeks et al., 2010, Himelein & Thatcher, 2006, Li et al., 
2011, Upadhya &Trent, 2003, Zhao et al., 2009).   
Informed Consent          
 Because the current study evaluated depression, participants were required to 
electronically sign their full name and provide an email address to signify informed 
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consent (see Appendix A).  This was done to decrease possible risks associated with 
depression and to increase safety of the participants.  Full disclosure of identity and 
contact information allowed the researcher to follow-up with a participant if she scored as 
depressed.  Participants who scored as depressed were emailed by the researcher and 
advised to immediately seek psychological evaluation from a healthcare provider.   
Design 
 This correlational study was conducted to compare BMI and depression in women 
with PCOS.  Data was obtained by survey (see Appendix B).  The study only involved a 
one-time data collection.  The survey consisted of 25 questions, including the CES-D 
questionnaire.  It was estimated that the survey would take about 20 minutes to complete.  
After the CES-D, five additional questions asked the participant to report her weight, 
height, comorbidities, age, and race.  After taking the survey, the participant's 
involvement in the research was complete.  Data was analyzed using Pearson’s 
correlation coefficient to determine if there is a relationship between body mass and 
depression in Mississippi women with PCOS.    
Depression Rating Questionnaire  
In the current study the CES-D was used to measure depression.  The CES-D is a 
valid and reliable 20 item questionnaire that scores depressive symptoms on a scale of 0-
60, with a score of > 16 indicating a risk for depressive episodes.  The CES-D was 
created to evaluate depressive symptoms in the general population (Radloff, 1977).  
Using the coefficient alpha, the internal consistency is about .85 for the general 
population.  In patient samples the internal consistency is about .90.  Test reliability is 
moderate (.45-.70).  The CES-D has been found to be useful in evaluating depressive 
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symptoms in specific populations such as patients with spinal cord injuries (Miller, 
Anton, & Townson, 2008). 
Body Mass Measurement  
 To measure body mass, BMI was used.  BMI is a person’s weight in relation to 
height.  It is found by dividing weight in kilograms by the square of height in meters or 
by dividing weight in pounds by the square of height in inches multiplied by 703.  
Because the United States uses customary units, and because participants were asked to 
report their weight in pounds and their height in inches, the latter equation was used to 
calculate each participant’s BMI.  For the purpose of this study BMI scores are classified 
as follows: <18.5 kg/m2 (underweight), 18.5-24 kg/m2 (normal weight), 25-29 kg/m2 
(overweight), 30-34 kg/m2 (class I obesity), 35-39 kg/m2 (class II obesity) and >40 
kg/m2 (class III obesity).  The American Medical Association (2010) and WHO (2006) 
established these BMI classifications. 
Procedures 
The survey was created and distributed using qualtrics.com, an online survey 
platform.  The researcher created a password protected Qualtrics account through the 
University of Southern Mississippi to ensure that participant data would be kept secure 
and confidential.   
Originally, an advertisement to recruit participants was posted to various PCOS 
support group websites.  However, this strategy failed to attract participants.  A 
modification form was then submitted to the Institutional Review Board of the University 
of Southern Mississippi asking if the researcher could individually contact members of 
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pcoschallenge.com.  After receiving approval (Appendix C), the recruitment document 
(see Appendix D) containing a link to the survey was messaged to eligible participants. 
The website, pcoschallenge.com allowed the researcher to identify members from 
Mississippi by conducting an advanced search by member location.  These search results 
consisted of a list of members who chose to share their location with others.  The terms 
“Mississippi” and “MS” were used to search member location.  The term “Mississippi” 
yielded one search result.  The term “MS” yielded 123 search results with only 106 of 
those results using “MS” as an abbreviation for “Mississippi”.  After eliminating 17 
search results in which “MS” did not stand for “Mississippi,” 106 members were invited 
to participate.  
Survey distribution consisted of personally messaging about 106 members of the 
online PCOS support group, pcoschallenge.com.  The personal message included a brief 
recruitment document, which provided a link to the survey.  Participation was completely 
voluntary.  Informed consent required that the participant disclose her full name as well 
as an email address for follow-up purposes.  Over the course of four weeks, five 
participants completed the survey.  At the fourth week mark, nonrespondents were 
messaged a reminder that the survey was still active.  After this reminder five more 
participants completed the survey.  The survey was available for four weeks and three 
days in total. 
After data was collected, the researcher scored the participants’ CES-D 
questionnaires and calculated the participants’ BMI.  If a participant scored as depressed, 
she received a follow-up email as previously discussed.  Participants’ BMI and CES-D 
scores were analyzed using Pearson’s r.  
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Power 
 For the current study to have 75% power a minimum of 77 participants were 
needed.  With only 10 participants the current study has 8% power. 
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Chapter IV 
Results 
The study included ten participants ranging from 21-54 years of age.  Nine 
participants identified as white.  One participant identified as Hispanic or Latino.   Six of 
the ten participants reported having been diagnosed with a condition or conditions other 
than PCOS.  Table 1 provides an overview of the demographics and characteristics of the 
participants (n = 10).   
Table I 
Participant Demographics and Characteristics 
Age  Number of participants 
21-34 8 
35-44 1 
45-54 1 
Race   
White 9 
Hispanic or Latino 1 
Participants reporting having a 
condition(s) other than PCOS 
 
Participants reporting other conditions 6 
Participants reporting no other conditions 4 
 
Two participants were classified as normal weight, one participant was classified 
as overweight, four participants were classified as class I obese, two participants were 
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classified as class II obese, and one participant was classified as class III obese.  Eight 
participants were overweight or obese.  Five of the ten participants scored > 16 on the 
CES-D, indicating that they are at risk for depressive episodes.   Table II provides 
descriptive statistics for all 10 participants (n = 10).   
Table II 
Descriptive Statistics (n = 10) 
  
n 
 
Minimum 
 
Maximum 
 
Mean 
Standard 
(Std.) 
Deviation 
BMI 10 23.01 62.02 35.7640 11.40096 
Depression 10 8.00 33.00 19.1000 9.55045 
 
SD for depression (SD = 9.55045) and to a lesser extent SD for BMI (SD = 
11.40096), indicated a large variation among participants.  The mean for BMI was 
calculated as 35.7640 while the mean for depression was calculated as 19.1000.  Note 
that the maximum BMI score of 62.02 and the minimum CES-D score of 8 belong to the 
same participant, who for the purpose of discussion will be referred to as participant 10.  
Because she possesses the maximum BMI score and the minimum CES-D score, 
participant 10 could be classified as an outlier affecting SD in this small sample of 
participants.   
Table III provides results for Pearson’s r correlation with BMI and CES-D scores 
from all 10 participants (n = 10).  With all 10 participants the BMI scores and CES-D 
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scores were negatively correlated (r = -0.173).  An r of  -0.173 indicates a low correlation 
between body mass and depression.      
Table III 
Correlations (n = 10) 
 BMI Depression 
BMI Pearson Correlation 1 -0.173 
BMI Sig. (2-tailed)  0.633 
Depression Pearson 
Correlation 
-0.173 1 
Depression Sig. (2-tailed) .633  
 
For experimental purposes the data was analyzed again without participant 10’s 
BMI score or CES-D score.  Table IV provides descriptive statistics excluding participant 
10 (n = 9).  Without participant 10 the maximum BMI changed to 46.80 and minimum 
CES-D score changed to 10.00.  
Table IV 
Descriptive Statistics (n = 9) 
 n Minimum Maximum Mean Std. 
Deviation 
BMI 9 23.01 46.80 32.8467 7.10511 
Depression 9 10.00  33.00 20.3333 9.24662 
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Without participant 10’s data, the BMI and CES-D scores for the remaining nine 
participants were positively correlated (r = 0.294).  An r of 0.294 indicates a low 
correlation between body mass and depression.  Table V provides results for Pearson’s r 
correlation excluding participant 10’s BMI and CES-D scores (n = 9).   
Table V 
Correlations (n = 9) 
 BMI Depression 
BMI Pearson Correlation 1 0.294 
BMI Sig. (2-tailed)  0.442 
Depression Pearson 
Correlation 
0.294 1 
Depression Sig. (2-tailed) 0.442  
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Chapter V 
Discussion 
Findings  
The current study found that five of the participants were experiencing clinically 
significant depressive symptoms (CES-D score > 16), which indicates a prevalence of 
depression among participants.  Previously, it has been reported that about 14–67% of 
women with PCOS suffer from depression (Dokras, Clifton, Futterweit, & Wild, 2011).  
Therefore, the 50% rate of depression among this sample was expected. 
With the inclusion of participant 10’s data, the finding that body mass and 
depression were negatively correlated does not reflect the findings of past research.  In 
women with PCOS, body mass and depression have been found by researchers to be 
positively correlated (Barry et al., 2011).  According to the current study’s findings 
including participant 10, a woman with an obese body mass has a lesser risk of being 
depressed than a woman with a normal body mass.  This finding also conflicts with the 
findings of studies that have evaluated the relationship between body mass and 
depression in the general population (Zhao et al., 2009).   
 Considering participant 10’s outlier value for BMI (BMI = 62.02) as well as her 
outlier value for depression (CES-D = 8), she may have provided too much variability for 
such a small sample population (n = 10), thus skewing results.  To test this conjecture, the 
data was analyzed without using participant 10’s data.   
 Excluding participant 10’s data, the results indicated a positive correlation 
between body mass and depression (r = 0.294).  These results were congruent with the 
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findings of past research (Barry et al., 2011).  Furthermore, the results indicated a 
moderate relationship between body mass and depression.   
The findings of this study are conflicting.  In the current study p > 0.05.  
Therefore, the results are not clinically significant.  However, it is recommended that 
healthcare providers screen all women with PCOS from Mississippi for depression.  Past 
research as well as the current study found that a correlation between body mass and 
depression does exist in women with PCOS so healthcare providers should not ignore 
patients’ psychological health.  If depression is identified and treated, a woman’s PCOS 
outcome might be improved (Katon & Ciechhanowski, 2002).   
Limitations and Cautions 
Limitations to this study include a small sample size.  The results and conclusions 
of this study may not be suitable for generalization.  Because of the low response rate, 
women with chronic diseases other than PCOS were included in this study.  Due to the 
fact that chronic disease contributes to depression, the results may have been skewed.   
The current study is limited due to the fact that individuals without access to the 
Internet are not represented.  Because personal information was requested over the 
Internet (full name and email address), the response rate may have been negatively 
affected (Jeavons, 2000).   
Recommendations for Future Study 
The current study aimed to evaluate the relationship between body mass and 
depression in Mississippi women with PCOS.  Future research could be conducted to 
examine cause and effect.  Other factors that might contribute to depression in 
Mississippi women with PCOS including less education, nonprofessional occupations, 
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smoking history, and taking hormones, could be investigated (Cipkala-Gaffin, Talbott, 
Song, Bromberger and Wilson, 2012).  Future research needs to be conducted with a 
larger sample to further examine the relationship between body mass and depression in 
Mississippi women with PCOS.    
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Appendix A 
 
 
THE UNIVERSITY OF SOUTHERN MISSISSIPPI 
AUTHORIZATION TO PARTICIPATE IN RESEARCH 
PROJECT 
 
Consent is hereby given to participate in the study titled: 
Body Mass and Depression among Mississippi Women with PCOS 
 
1. Purpose:  Thank you for your interest in this research.  This study is being done 
to investigate a possible relationship between body mass and depression among 
Mississippi women with polycystic ovarian syndrome (PCOS).  This study is 
being performed to fulfill a thesis requirement for graduation from the Honors 
College of the Univeristy of Southern Mississippi.  The results of this study will 
be published by the University of Southern Mississippi.  The results may be 
published or presented elsewhere in an academic setting.   
 
2. Description of Study:  Participation involves filling out a 25 question survey 
that takes no more than 20 minutes to complete.  20 of the 25 questions are 
multiple choice and include questions about your emotions and lifestyle.  The 
5 remaining questions ask you to fill out demographic information as well as 
height and weight.  The survey answers will be kept confidential and the 
answers will only be used for this thesis study.  You do not have to answer 
questions that make you uncomfortable.  If you change your mind about 
participation while taking the survey, you may exit the survey by closing the 
browser window.      
 
3. Benefits: There is no compensation for completion of this study, but 
know that by participating in this study you will be contributing to 
existing and future research about PCOS and how it affects mental 
health. 
 
4. Risks:  Risks include an increased awareness of your mental state, particularly a 
state of depression.  If this happens to you, you should immediately contact a 
national crisis hotline such as the United Way Helpline (1-800-233-HELP), or a 
national suicide crisis hotline such as the National Hopeline Center (1-800-784-
2433), and/or your healthcare provider.  If you are in a medical emergency or a 
suicidal crisis please call 911.  The University of Southern Mississippi has no 
mechanism to provide compensation for participants who may incur injuries as a 
result of participating in research projects. However, efforts will be made to 
make available the facilities and professional skills at the University.  
 
5. Confidentiality: The following steps will be taken to keep information about 
you confidential and to protect it from unauthorized disclosure:  Survey 
answers will be password protected on the researcher’s Qualtrics.com account.  
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Only the researcher can access this information.  When transferring the survey 
answers to a spreadsheet for data analysis, any identifying information will be 
excluded (such as your full name).  Any identifying information will only be 
accessible by the researcher through the password protected Qualtrics.com 
account.  Only survey answers will be used in the written thesis.  Any 
identifying information will not be used in the thesis.  Answers will be kept 
confidential.  Likewise, any identifying information will be kept confidential.  
If you choose to email the researcher or the researcher’s supervisor, your 
identifying information will not be released to anyone, and the emails will be 
promptly deleted after each correspondence.  After publication of the thesis all 
data will be deleted from the researcher’s computer and the researcher’s 
qualtrics.com account will be deactivated.    
  
6. Participant's Assurance:  Whereas no assurance can be made concerning 
results that may be obtained (since results from investigational studies 
cannot be predicted) the researcher will take every precaution consistent 
with the best scientific practice. Participation in this project is completely 
voluntary, and participants may withdraw from this study at any time 
without penalty, prejudice, or loss of benefits. 
 
7. Questions? Questions concerning the research should be directed to the 
researcher, Laurel Bruce at laurel.bruce@eagles.usm.edu or to the 
researcher’s supervisor at Elizabeth.Tinnon@.usm.edu.  This project and 
this consent form have been reviewed by the Institutional Review Board, 
which ensures that research projects involving human subjects follow 
federal regulations. Any questions or concerns about rights as a research 
participant should be directed to the Chair of the Institutional Review 
Board, The University of Southern Mississippi, 118 College Drive #5116, 
Hattiesburg, MS 39406-0001, (601) 266-5997. A copy of this form will be 
given to the participant. 
 
8. Signatures:  In conformance with the federal guidelines, the signature of the 
participant must appear on all written consent documents.  
 
_______________________________                       ____________________ 
 
Signature of Research Participant    Date 
 
Please list an email address below so that you can receive a follow-up email from 
the researcher if you score as being at risk for depression: 
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Additional Survey Questions 
 
 
1. List your height: 
 
2. List your weight: 
 
3. Have you been diagnosed with a medical condition/conditions other than PCOS?  If so 
please list it here: 
 
4. Select your age: 
a. 21-34 years 
b. 35-44 years   
c. 45-54 years 
d. 54+ years 
 
5. Select your race: 
a. Hispanic or Latino 
b. American Indian or Native Alaskan 
c. Asian 
d. Black or African American 
e. Native Hawaiian or Other Pacific Islander 
f. White or Caucasian  
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Appendix D 
 
Recruitment Document 
 
 I, Laurel Bruce, am an undergraduate nursing student at the University of 
Southern Mississippi seeking participants for a thesis study investigating body mass and 
depression among Mississippi women with polycystic ovarian syndrome (PCOS).   
 
Participation involves filling out a 25 question online survey that should take no more 
than 20 minutes of your time.  To participate you must be 18 or older, you must have 
received a diagnosis of PCOS from a gynecologist or endocrinologist, and you must be a 
current resident of the state of Mississippi.   
 
If you agree to participate you will complete the survey at: [hyperlink].  Your survey 
answers will be kept confidential, and the answers will only be used for this thesis study.  
Any identifying information will not be included in the thesis and will be kept 
confidential.  You do not have to answer questions that make you uncomfortable.  If you 
change your mind about participation while taking the survey, you may exit the survey.   
 
The results of this study may be published and/or presented in the academic setting.  If 
you have any questions or concerns about the study please contact the researcher, Laurel 
Bruce, at laurel.bruce@eagles.usm.edu.  This research is being conducted under the 
supervision of Dr. Elizabeth Tinnon who can be contacted at elizabeth.tinnon@usm.edu.  
 
This project has been reviewed by the Human Subjects Protection Review Committee, 
which ensures that research projects involving human subjects follow federal regulations. 
Any questions or concerns about rights as a research subject should be directed to the 
Chair of the Institutional Review Board, The University of Southern Mississippi, 118 
College Drive #5147, Hattiesburg, MS  39406-0001, (601) 266-6820. 
 
Thank you for your consideration, 
Laurel Bruce 
 
